Histological evidence for nonperfused vasculature in a murine tumor following hydralazine administration
- 1 October 1989
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 17 (4), 785-789
- https://doi.org/10.1016/0360-3016(89)90067-9
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Use of a carbocyanine dye as a marker of functional vasculature in murine tumoursBritish Journal of Cancer, 1989
- The use of fluorescent probes to identify regions of transient perfusion in murine tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Imaging system for morphometric assessment of absorption or fluorescence in stained cellsCytometry, 1988
- Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazineBritish Journal of Cancer, 1988
- Effects of Hydralazine-Induced Vasodilation on the Energy Metabolism of Murine Tumors Studied by In Vivo31P-Nuclear Magnetic Resonance Spectroscopy1JNCI Journal of the National Cancer Institute, 1988
- The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gainInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Tumor Blood Flow-Characterization, Modifications, and Role in HyperthermiaIEEE Transactions on Sonics and Ultrasonics, 1984
- Abnormal Response of Tumor Vasculature to Vasoactive Drugs23JNCI Journal of the National Cancer Institute, 1984
- HydralazineNew England Journal of Medicine, 1976
- Blood flow and oxygenation of tumors in mice.II. Effects of vasodilator drugsCancer, 1967